546 related articles for article (PubMed ID: 29187467)
21. Prostate Mapping for Cancer Diagnosis: The Madrid Protocol. Transperineal Prostate Biopsies Using Multiparametric Magnetic Resonance Imaging Fusion and Micro-Ultrasound Guided Biopsies.
Rodríguez Socarrás ME; Gomez Rivas J; Cuadros Rivera V; Reinoso Elbers J; Llanes González L; Michel Mercado I; Fernandez Del Alamo J; Juarez Del Dago P; Sancha FG
J Urol; 2020 Oct; 204(4):726-733. PubMed ID: 32314932
[TBL] [Abstract][Full Text] [Related]
22. Gleason Score Determination with Transrectal Ultrasound-Magnetic Resonance Imaging Fusion Guided Prostate Biopsies--Are We Gaining in Accuracy?
Lanz C; Cornud F; Beuvon F; Lefèvre A; Legmann P; Zerbib M; Delongchamps NB
J Urol; 2016 Jan; 195(1):88-93. PubMed ID: 26165586
[TBL] [Abstract][Full Text] [Related]
23. Assessing clinically significant prostate cancer: Diagnostic properties of multiparametric magnetic resonance imaging compared to three-dimensional transperineal template mapping histopathology.
Tsivian M; Gupta RT; Tsivian E; Qi P; Mendez MH; Abern MR; Tay KJ; Polascik TJ
Int J Urol; 2017 Feb; 24(2):137-143. PubMed ID: 27859637
[TBL] [Abstract][Full Text] [Related]
24. Added Value of Multiparametric Ultrasonography in Magnetic Resonance Imaging and Ultrasonography Fusion-guided Biopsy of the Prostate in Patients With Suspicion for Prostate Cancer.
Maxeiner A; Stephan C; Durmus T; Slowinski T; Cash H; Fischer T
Urology; 2015 Jul; 86(1):108-14. PubMed ID: 26142593
[TBL] [Abstract][Full Text] [Related]
25. Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies.
Pokorny MR; de Rooij M; Duncan E; Schröder FH; Parkinson R; Barentsz JO; Thompson LC
Eur Urol; 2014 Jul; 66(1):22-9. PubMed ID: 24666839
[TBL] [Abstract][Full Text] [Related]
26. Comparative Effectiveness of Targeted Prostate Biopsy Using Magnetic Resonance Imaging Ultrasound Fusion Software and Visual Targeting: a Prospective Study.
Lee DJ; Recabal P; Sjoberg DD; Thong A; Lee JK; Eastham JA; Scardino PT; Vargas HA; Coleman J; Ehdaie B
J Urol; 2016 Sep; 196(3):697-702. PubMed ID: 27038768
[TBL] [Abstract][Full Text] [Related]
27. The Efficacy of Multiparametric Magnetic Resonance Imaging and Magnetic Resonance Imaging Targeted Biopsy in Risk Classification for Patients with Prostate Cancer on Active Surveillance.
Recabal P; Assel M; Sjoberg DD; Lee D; Laudone VP; Touijer K; Eastham JA; Vargas HA; Coleman J; Ehdaie B
J Urol; 2016 Aug; 196(2):374-81. PubMed ID: 26920465
[TBL] [Abstract][Full Text] [Related]
28. PI-RADS Version 2 Category on 3 Tesla Multiparametric Prostate Magnetic Resonance Imaging Predicts Oncologic Outcomes in Gleason 3 + 4 Prostate Cancer on Biopsy.
Faiena I; Salmasi A; Mendhiratta N; Markovic D; Ahuja P; Hsu W; Elashoff DA; Raman SS; Reiter RE
J Urol; 2019 Jan; 201(1):91-97. PubMed ID: 30142318
[TBL] [Abstract][Full Text] [Related]
29. Manually controlled targeted prostate biopsy with real-time fusion imaging of multiparametric magnetic resonance imaging and transrectal ultrasound: an early experience.
Shoji S; Hiraiwa S; Endo J; Hashida K; Tomonaga T; Nakano M; Sugiyama T; Tajiri T; Terachi T; Uchida T
Int J Urol; 2015 Feb; 22(2):173-8. PubMed ID: 25316213
[TBL] [Abstract][Full Text] [Related]
30. Missing the Mark: Prostate Cancer Upgrading by Systematic Biopsy over Magnetic Resonance Imaging/Transrectal Ultrasound Fusion Biopsy.
Muthigi A; George AK; Sidana A; Kongnyuy M; Simon R; Moreno V; Merino MJ; Choyke PL; Turkbey B; Wood BJ; Pinto PA
J Urol; 2017 Feb; 197(2):327-334. PubMed ID: 27582434
[TBL] [Abstract][Full Text] [Related]
31. [Real-time MRI/US fusion-guided biopsy in biopsy-naïve and pre-biopsied patients with suspicion for prostate cancer].
Maxeiner A; Stephan C; Fischer T; Durmus T; Kilic E; Asbach P; Haas M; Günzel K; Neymeyer J; Miller K; Cash H
Aktuelle Urol; 2015 Jan; 46(1):34-8. PubMed ID: 25519051
[TBL] [Abstract][Full Text] [Related]
32. Multiparametric magnetic resonance imaging and ultrasound fusion biopsy detect prostate cancer in patients with prior negative transrectal ultrasound biopsies.
Vourganti S; Rastinehad A; Yerram N; Nix J; Volkin D; Hoang A; Turkbey B; Gupta GN; Kruecker J; Linehan WM; Choyke PL; Wood BJ; Pinto PA
J Urol; 2012 Dec; 188(6):2152-2157. PubMed ID: 23083875
[TBL] [Abstract][Full Text] [Related]
33. Prostate cancer detection with magnetic resonance-ultrasound fusion biopsy: The role of systematic and targeted biopsies.
Filson CP; Natarajan S; Margolis DJ; Huang J; Lieu P; Dorey FJ; Reiter RE; Marks LS
Cancer; 2016 Mar; 122(6):884-92. PubMed ID: 26749141
[TBL] [Abstract][Full Text] [Related]
34. Determination of the Role of Negative Magnetic Resonance Imaging of the Prostate in Clinical Practice: Is Biopsy Still Necessary?
Wang RS; Kim EH; Vetter JM; Fowler KJ; Shetty AS; Mintz AJ; Badhiwala NG; Grubb RL; Andriole GL
Urology; 2017 Apr; 102():190-197. PubMed ID: 27845218
[TBL] [Abstract][Full Text] [Related]
35. Impact of Lesion Visibility on Transrectal Ultrasound on the Prediction of Clinically Significant Prostate Cancer (Gleason Score 3 + 4 or Greater) with Transrectal Ultrasound-Magnetic Resonance Imaging Fusion Biopsy.
Garcia-Reyes K; Nguyen HG; Zagoria RJ; Shinohara K; Carroll PR; Behr SC; Westphalen AC
J Urol; 2018 Mar; 199(3):699-705. PubMed ID: 28941918
[TBL] [Abstract][Full Text] [Related]
36. Multiparametric-Magnetic Resonance/Ultrasound Fusion Targeted Prostate Biopsy Improves Agreement Between Biopsy and Radical Prostatectomy Gleason Score.
Porpiglia F; DE Luca S; Passera R; Manfredi M; Mele F; Bollito E; DE Pascale A; Cossu M; Aimar R; Veltri A
Anticancer Res; 2016 Sep; 36(9):4833-9. PubMed ID: 27630337
[TBL] [Abstract][Full Text] [Related]
37. Additional value of magnetic resonance-targeted biopsies to standard transrectal ultrasound-guided biopsies for detection of clinically significant prostate cancer.
von Below C; Wassberg C; Norberg M; Tolf A; Kullberg J; Ladjevardi S; Häggman M; Bill Axelson A; Ahlström H
Scand J Urol; 2017 Apr; 51(2):107-113. PubMed ID: 28635568
[TBL] [Abstract][Full Text] [Related]
38. Prostate cancer detection using multiparametric 3 - tesla MRI and fusion biopsy: preliminary results.
Mussi TC; Garcia RG; Queiroz MR; Lemos GC; Baroni RH
Int Braz J Urol; 2016; 42(5):897-905. PubMed ID: 27532112
[TBL] [Abstract][Full Text] [Related]
39. Multiparametric magnetic resonance imaging guided diagnostic biopsy detects significant prostate cancer and could reduce unnecessary biopsies and over detection: a prospective study.
Thompson JE; Moses D; Shnier R; Brenner P; Delprado W; Ponsky L; Pulbrook M; Böhm M; Haynes AM; Hayen A; Stricker PD
J Urol; 2014 Jul; 192(1):67-74. PubMed ID: 24518762
[TBL] [Abstract][Full Text] [Related]
40. Identification of threshold prostate specific antigen levels to optimize the detection of clinically significant prostate cancer by magnetic resonance imaging/ultrasound fusion guided biopsy.
Shakir NA; George AK; Siddiqui MM; Rothwax JT; Rais-Bahrami S; Stamatakis L; Su D; Okoro C; Raskolnikov D; Walton-Diaz A; Simon R; Turkbey B; Choyke PL; Merino MJ; Wood BJ; Pinto PA
J Urol; 2014 Dec; 192(6):1642-8. PubMed ID: 25117476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
